Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 062422
Company: BAXTER HLTHCARE

Products on ANDA 062422

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	EQ 20MG BASE/ML	INJECTABLE;INJECTION	Discontinued	None	No	No
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	EQ 40MG BASE/ML	INJECTABLE;INJECTION	Discontinued	None	No	No
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	EQ 20MG BASE/ML	INJECTABLE;INJECTION	Discontinued	None	No	No
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	EQ 40MG BASE/ML	INJECTABLE;INJECTION	Discontinued	None	No	No
CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	EQ 20MG BASE/ML	INJECTABLE;INJECTION	Discontinued	None	No	No
CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER	CEPHALOTHIN SODIUM	EQ 40MG BASE/ML	INJECTABLE;INJECTION	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 062422

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/31/1984	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/16/1991	SUPPL-12	Labeling		Label is not available on this site.